Open for bids Tender Germany ICB TOT Ref. 152539580

Conclusion not Excluding Drug Discount Agreement. Tender - 152539580

Tender notice from Germany, published on 16 Nov 2026.

Executive Summary

Title/Summary: Tender for non-exclusive discount agreements for the drug Pazopanib under an Open-House model issued by AOK PLUS, located in Erfurt, Germany. The contract will be valid until January 31, 2029, with initial applications due by January 5, 2027.

Scope Of Work: The tender involves establishing non-exclusive discount agreements for the drug Pazopanib (ATC Code: L01EX03) in accordance with § 130a Abs. 8 SGB V. The agreements will be open to all interested pharmaceutical companies during the participation period, without individual contract negotiations or exclusivity. The quantities to be purchased are unpredictable, dependent on demand and other factors. Interested companies must download participation documents from the German Procurement Portal (DTVP) after applying for access. Confidentiality of the agreement terms is mandatory.

Qualification Criterion: Pharmaceutical companies interested in participating must fulfill specified participation requirements and accept the terms outlined in the participation documents. They must submit necessary documentation as detailed in the DTVP portal. The tender does not guarantee minimum purchase quantities, and all submitted materials must be destroyed if participation is declined. The submission of participation applications begins on January 5, 2027, with further deadlines available in the project documents.

Key facts

Summary
Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Pazopanib (Atc Code According to Who: L01ex03)
TOT Ref. No.
152539580
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
16 Nov 2026
Bid deadline
31 Jan 2029
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Pazopanib (Atc Code According to Who: L01ex03) is 31 Jan 2029. Submit before this date to be considered.

This tender has been issued by AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152539580. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.